Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rh Blood Group01:19

Rh Blood Group

1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Blood Typing01:10

Blood Typing

1.2K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trial.

npj drug discovery·2026
Same author

Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sites.

Science translational medicine·2026
Same author

T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthood.

Human vaccines & immunotherapeutics·2026
Same author

Natural SARS-CoV-2 infection in farmed minks <i>(Neovison vison)</i> causes lung pathology, systemic viral spread, and transmission risk, even in asymptomatic animals.

Frontiers in veterinary science·2026
Same author

Pre-assembly of biomolecular condensate seeds drives RSV replication.

Nature·2026
Same author

Distinct Effects of Autologous Hematopoietic Stem Cell Transplantation on T Cell Composition and Profile in Refractory Crohn's Disease.

Inflammatory bowel diseases·2026

Related Experiment Video

Updated: Jun 19, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K

RSV Neutralizing Antibodies in Dried Blood.

Jonne Terstappen1,2, Eveline M Delemarre2, Anouk Versnel2

  • 1Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

The Journal of Infectious Diseases
|July 25, 2024
PubMed
Summary

Dried blood spot testing accurately measures respiratory syncytial virus (RSV) neutralization, offering a simpler alternative to traditional blood draws for vaccine and antibody trials. This patient-centered approach simplifies sample collection and processing.

Keywords:
antibodiesclinical trialsdried bloodrespiratory syncytial virusvaccine

More Related Videos

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
05:53

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay

Published on: December 7, 2021

4.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Related Experiment Videos

Last Updated: Jun 19, 2025

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K
A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay
05:53

A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay

Published on: December 7, 2021

4.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

7.9K

Area of Science:

  • Virology
  • Immunology
  • Clinical Trials

Background:

  • Respiratory syncytial virus (RSV) neutralization is key for vaccine and monoclonal antibody (mAb) efficacy.
  • Traditional serology requires venipuncture, complicating sample acquisition, processing, storage, and transport in clinical trials.
  • Dried blood spot (DBS) sampling offers a simplified, cost-effective alternative.

Purpose of the Study:

  • To validate an assay for measuring RSV neutralization using dried capillary blood.
  • To assess the feasibility of DBS sampling as a patient-centered solution in clinical trials.

Main Methods:

  • Comparison of functional antibodies in matched serum and DBS samples from a Phase 1 trial of an anti-RSV prefusion F mAb (RSM01).
  • Quantification of half-maximal inhibitory concentration (IC50) using RSV-A2-mKate and Hep-2 cells.
  • Evaluation of DBS sample stability over time and under temperature stress.

Main Results:

  • High correlation (R2 = 0.98, P < .0001) between functional antibodies in DBS and serum.
  • Assay precision for DBS was comparable to serum.
  • mAb function remained stable in DBS for 9 months at room temperature and when frozen.

Conclusions:

  • Feasibility demonstrated for measuring RSV neutralization via DBS.
  • DBS testing presents a patient-centered alternative to serology for RSV and potentially other viral infections (influenza, SARS-CoV-2).
  • This method can streamline clinical trials and reduce associated costs.